{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T19:54:28Z","timestamp":1767210868540},"reference-count":26,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2006,1,1]],"date-time":"2006-01-01T00:00:00Z","timestamp":1136073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Pharmaceutics"],"published-print":{"date-parts":[[2006,1]]},"DOI":"10.1016\/j.ijpharm.2005.09.033","type":"journal-article","created":{"date-parts":[[2005,11,22]],"date-time":"2005-11-22T07:31:18Z","timestamp":1132644678000},"page":"182-187","source":"Crossref","is-referenced-by-count":6,"title":["Monitoring the ingestion of anti-tuberculosis drugs by simple non-invasive methods"],"prefix":"10.1016","volume":"307","author":[{"given":"F.A.","family":"Sirgel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.S.","family":"Maritz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Venter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Langdon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.J.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.R.","family":"Donald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ijpharm.2005.09.033_bib1","doi-asserted-by":"crossref","first-page":"108","DOI":"10.2165\/00003088-197803020-00002","article-title":"Clinical pharmacokinetics of rifampicin","volume":"3","author":"Acocella","year":"1978","journal-title":"Clin. Pharmacokinet"},{"key":"10.1016\/j.ijpharm.2005.09.033_bib2","first-page":"981","article-title":"Monitoring regularity of drug intake in tuberculous patients by means of simple urine tests","volume":"57","author":"Burkardt","year":"1980","journal-title":"S. Afr. Med. J."},{"key":"10.1016\/j.ijpharm.2005.09.033_bib3","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1136\/bmj.325.7375.1282","article-title":"Current medical treatment for tuberculosis","volume":"325","author":"Chan","year":"2002","journal-title":"Br. Med. J."},{"issue":"8","key":"10.1016\/j.ijpharm.2005.09.033_bib4","first-page":"693","article-title":"The early bactericidal activity of streptomycin","volume":"6","author":"Donald","year":"2002","journal-title":"Int. J. Tuberc. Lung Dis."},{"key":"10.1016\/j.ijpharm.2005.09.033_bib5","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1586\/14787210.1.1.141","article-title":"Early bactericidal activity of anti-tuberculosis agents","volume":"1","author":"Donald","year":"2003","journal-title":"Expert. Rev. Anti-infect. Ther."},{"key":"10.1016\/j.ijpharm.2005.09.033_bib6","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1016\/S0140-6736(05)63457-5","article-title":"Monitoring compliance with antituberculous treatment by detection of isoniazid in urine","volume":"350","author":"Elizaga","year":"1997","journal-title":"The Lancet."},{"key":"10.1016\/j.ijpharm.2005.09.033_bib7","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1136\/jcp.30.1.84","article-title":"A sensitive urine-test method for monitoring the ingestion of isoniazid","volume":"30","author":"Ellard","year":"1977","journal-title":"J. Clin. Path."},{"key":"10.1016\/j.ijpharm.2005.09.033_bib8","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1164\/arrd.1972.106.6.923","article-title":"Reagent-impregnated paper strip for detection of metabolic products of isoniazid in urine","volume":"106","author":"Kilburn","year":"1972","journal-title":"Am. Rev. Respir. Dis."},{"key":"10.1016\/j.ijpharm.2005.09.033_bib9","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1378\/chest.113.5.1178","article-title":"Low serum antimycobacterial drug levels in non-HIV-infected tuberculosis patients","volume":"113","author":"Kimberling","year":"1998","journal-title":"Chest"},{"key":"10.1016\/j.ijpharm.2005.09.033_bib10","series-title":"The use of Antibiotics. A Clinical Review of Antibacterial, Antifungal and Antiviral Drugs","first-page":"676","article-title":"Part 1, antibiotics: rifampicin (rifampin)","author":"Kucers","year":"1997"},{"issue":"7","key":"10.1016\/j.ijpharm.2005.09.033_bib11","first-page":"862","article-title":"Consecutive-dose pharmacokinetics of rifapentine in patients diagnosed with pulmonary tuberculosis","volume":"8","author":"Langdon","year":"2004","journal-title":"Int. J. Tuberc. Lung Dis."},{"issue":"6","key":"10.1016\/j.ijpharm.2005.09.033_bib12","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/S0895-4356(99)00027-X","article-title":"Detection of antimicrobial activity in urine for epidemiologic studies of antibiotic use","volume":"52","author":"Liu","year":"1999","journal-title":"J. Clin. Epidemiol."},{"issue":"4","key":"10.1016\/j.ijpharm.2005.09.033_bib13","first-page":"356","article-title":"Widespread distribution of a single drug rifampicin formulation of inferior bioavailability in South Africa","volume":"6","author":"McIlleron","year":"2002","journal-title":"Int. J. Tuberc. Lung Dis."},{"key":"10.1016\/j.ijpharm.2005.09.033_bib14","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1378\/chest.120.5.1520","article-title":"Utility of rifampin blood levels in the treatment and follow-up of active pulmonary tuberculosis in patients who were slow to respond to routine directly observed therapy","volume":"120","author":"Mehta","year":"2001","journal-title":"Chest"},{"issue":"10","key":"10.1016\/j.ijpharm.2005.09.033_bib15","first-page":"903","article-title":"The value of urine testing for verifying adherence to anti-tuberculosis chemotherapy in children and adults in Uganda","volume":"6","author":"Meissner","year":"2002","journal-title":"Int. J. Tuberc. Lung Dis."},{"key":"10.1016\/j.ijpharm.2005.09.033_bib16","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/0041-3879(70)90023-1","article-title":"Detection of rifampicin in urine by a simple microbiological assay","volume":"51","author":"Mitchison","year":"1970","journal-title":"Tuberculosis"},{"key":"10.1016\/j.ijpharm.2005.09.033_bib17","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S0895-4356(98)00033-X","article-title":"Comparison of three composite compliance indices in a trial of self-administered preventive therapy for tuberculosis in HIV-infected Ugandan adults","volume":"51","author":"Pekovic","year":"1998","journal-title":"J. Clin. Epidemiol."},{"issue":"15","key":"10.1016\/j.ijpharm.2005.09.033_bib18","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.2165\/00003495-200262150-00001","article-title":"Therapeutic drug monitoring in the treatment of tuberculosis","volume":"62","author":"Peloquin","year":"2002","journal-title":"Drugs"},{"key":"10.1016\/j.ijpharm.2005.09.033_bib19","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1046\/j.1445-5994.2003.00390.x","article-title":"Managing antituberculosis drug therapy by therapeutic drug monitoring of rifampicin and isoniazid","volume":"33","author":"Ray","year":"2003","journal-title":"Int. Med. J."},{"key":"10.1016\/j.ijpharm.2005.09.033_bib20","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1378\/chest.98.2.314","article-title":"Testing for isoniazid\u2014an evaluation of the Arkansas method","volume":"98","author":"Schraufnagel","year":"1990","journal-title":"Chest"},{"key":"10.1016\/j.ijpharm.2005.09.033_bib21","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/0378-4347(96)82886-6","article-title":"High-performance liquid chromatographic determination of isoniazid, acetylisoniazid and hydrazine in biological fluids","volume":"674","author":"Seifart","year":"1995","journal-title":"J. Chromatogr. B: Biomed. Appl."},{"key":"10.1016\/j.ijpharm.2005.09.033_bib22","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1093\/jac\/45.6.859","article-title":"A multicentre study of the early bactericidal activity of antituberculosis drugs","volume":"45","author":"Sirgel","year":"2000","journal-title":"J. Antimic. Chem."},{"key":"10.1016\/j.ijpharm.2005.09.033_bib23","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1164\/rccm.200411-1557OC","article-title":"The early bactericidal activities of rifampin and rifapentine in pulmonary tuberculosis","volume":"172","author":"Sirgel","year":"2005","journal-title":"Am. J. Resp. Crit. Care. Med."},{"issue":"11 Suppl. 3","key":"10.1016\/j.ijpharm.2005.09.033_bib24","first-page":"S325","article-title":"Determination of rifampicin, isoniazid and pyrazinamide by high performance liquid chromatography after their simultaneous extraction from plasma","volume":"3","author":"Smith","year":"1999","journal-title":"Int. J. Tuberc. Lung Dis."},{"issue":"6","key":"10.1016\/j.ijpharm.2005.09.033_bib25","doi-asserted-by":"crossref","first-page":"497","DOI":"10.5588\/09640569513002","article-title":"Low plasma concentrations of rifampicin in tuberculosis patients in Indonesia","volume":"6","author":"Van Crewel","year":"2002","journal-title":"Int. J. Tuberc. Lung Dis."},{"key":"10.1016\/j.ijpharm.2005.09.033_bib26","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1258\/0004563041731637","article-title":"Point-of-care test to monitor adherence to anti-tuberculous treatment","volume":"41","author":"Whitfield","year":"2004","journal-title":"Ann. Clin. Biochem."}],"container-title":["International Journal of Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517305006605?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517305006605?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,6]],"date-time":"2019-04-06T20:44:48Z","timestamp":1554583488000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378517305006605"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,1]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006,1]]}},"alternative-id":["S0378517305006605"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpharm.2005.09.033","relation":{},"ISSN":["0378-5173"],"issn-type":[{"value":"0378-5173","type":"print"}],"subject":[],"published":{"date-parts":[[2006,1]]}}}